Erik Amble
Fondateur chez Neomed Management AS
Profil
Erik Amble is the founder of Neomed Management AS, which was founded in 1998.
He is also the founder of Norwegian Venture Capital & Private Equity Association.
Dr. Amble's current jobs include being a Director at JenaValve Technology GmbH, Sequana Medical AG, JenaValve Technology, Inc., Corflow Therapeutics AG, and Serca Pharmaceuticals AS.
His former jobs include being a Director at Windy Hill Medical, Inc., Sonendo, Inc., Thommen Medical AG, GenoVision AS, InDex Pharmaceuticals Holding AB, Weifa ASA, Alertis Medical AS, Vessix Vascular, Inc., and Qiagen AS.
He was also an Independent Director at Axonics, Inc. from 2014 to 2020.
Additionally, Dr. Amble has held positions as a Non-Executive Director at Sequana Medical NV, an Associate at Glenwood Management, an Advisor at Omega Fund Management LLC, and the President of Origo Ventures AS.
He holds a doctorate degree from the University of Oslo and a graduate degree from Stanford Graduate School of Business.
Postes actifs de Erik Amble
| Sociétés | Poste | Début |
|---|---|---|
Neomed Management AS
 Neomed Management AS Investment ManagersFinance Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V. | Fondateur | 09/02/1998 |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Directeur/Membre du Conseil | - |
Sequana Medical AG
 Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Directeur/Membre du Conseil | - |
Corflow Therapeutics AG
 Corflow Therapeutics AG Medical SpecialtiesHealth Technology Corflow Therapeutics AG is a company based in Switzerland that is developing proprietary technologies to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time in the catheter laboratory. The Swiss company's focus is on treating microvascular obstruction (MVO) after an acute heart attack, which is documented to be an independent marker leading to costly complications such as heart failure. Corflow's technologies may enable interventional cardiologists to treat MVO in severe heart attack patients, thereby potentially reducing the short- and long-term complication rates in these patients. The company was founded in 2016 by Martin T. Rothman and Robert S. Schwartz. | Directeur/Membre du Conseil | - |
Serca Pharmaceuticals AS
 Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway. | Directeur/Membre du Conseil | - |
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Directeur/Membre du Conseil | - |
Anciens postes connus de Erik Amble
| Sociétés | Poste | Fin |
|---|---|---|
| SEQUANA MEDICAL N.V. | Directeur/Membre du Conseil | 07/09/2022 |
| AXONICS, INC. | Directeur/Membre du Conseil | 31/12/2020 |
Windy Hill Medical, Inc.
 Windy Hill Medical, Inc. Medical SpecialtiesHealth Technology Windy Hill Medical, Inc. manufactures and supplies medical devices. The firm focuses on the development of products to reduce the risk of breast cancer. The company was founded by Dr. Susan Love in 2004 and is headquartered in Laguna Hills, CA. | Directeur/Membre du Conseil | 28/05/2012 |
| ░░░░░ ░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | - |
| ░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░ | - |
Formation de Erik Amble
| University of Oslo | Doctorate Degree |
| Stanford Graduate School of Business | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| SONENDO, INC. | Health Technology |
| FLERIE INVEST AB | Health Technology |
| AXONICS, INC. | Health Technology |
| SEQUANA MEDICAL N.V. | Health Technology |
| Entreprise privées | 17 |
|---|---|
Windy Hill Medical, Inc.
Windy Hill Medical, Inc. Medical SpecialtiesHealth Technology Windy Hill Medical, Inc. manufactures and supplies medical devices. The firm focuses on the development of products to reduce the risk of breast cancer. The company was founded by Dr. Susan Love in 2004 and is headquartered in Laguna Hills, CA. | Health Technology |
Thommen Medical AG
 Thommen Medical AG Medical SpecialtiesHealth Technology Thommen Medical AG develops and manufactures dental implant systems. It offers include implants, prosthetics, digital solutions, and case planning. The company Grenchen, Switzerland. | Health Technology |
GenoVision AS
 GenoVision AS Medical SpecialtiesHealth Technology GenoVision AS develops reagents and solutions for certain nucleic acid diagnostic markets. It has developed products and protocols for the direct isolation of DNA and RNA from a variety of sample sources such as dried blood, leucocytes, serum, buccal cells, cultured cells, biopsy samples, paraffin embedded tissue sections, animal tissue and yeast cells. GenoVision was formed in 1998 and is headquartered in Oslo, Norway | Health Technology |
Weifa ASA
 Weifa ASA Pharmaceuticals: MajorHealth Technology Weifa ASA engages in the development, production and sales of medicines and other health products. Its products include medicines for pain relief, cough and cold, nutraceuticals, and dermatology. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
Neomed Management AS
Neomed Management AS Investment ManagersFinance Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V. | Finance |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Health Technology |
Alertis Medical AS
 Alertis Medical AS Medical DistributorsDistribution Services Alertis Medical AS was established in 2000 to develop and commercialize a unique technology for the early detection of critical conditions related to blood supply and respiration, addressing considerable unmet needs in medicine. The patented technology originates from the anesthesiologist Prof T. I. Tønnessen, MD, PhD, and the physicist P. Mirtaheri, PhD, at Rikshospitalet University Hospital, Oslo | Distribution Services |
Vessix Vascular, Inc.
 Vessix Vascular, Inc. Pharmaceuticals: OtherHealth Technology Vessix Vascular, Inc. develops products to treat artery disease. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | Health Technology |
Sequana Medical AG
Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Health Technology |
Glenwood Management
 Glenwood Management Real Estate DevelopmentFinance Glenwood Management develops, owns, manages, and rents apartments. The private company is based in New York, NY and has subsidiaries in the United States. | Finance |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Health Technology |
| Norwegian Venture Capital & Private Equity Association | |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Finance |
| Qiagen AS | |
Corflow Therapeutics AG
Corflow Therapeutics AG Medical SpecialtiesHealth Technology Corflow Therapeutics AG is a company based in Switzerland that is developing proprietary technologies to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time in the catheter laboratory. The Swiss company's focus is on treating microvascular obstruction (MVO) after an acute heart attack, which is documented to be an independent marker leading to costly complications such as heart failure. Corflow's technologies may enable interventional cardiologists to treat MVO in severe heart attack patients, thereby potentially reducing the short- and long-term complication rates in these patients. The company was founded in 2016 by Martin T. Rothman and Robert S. Schwartz. | Health Technology |
Serca Pharmaceuticals AS
Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway. | Health Technology |
| Origo Ventures AS |
